Pot stock, Elon Musk, Fed Reserve
Pot stocks are climbing and the Federal Reserve’s chair has called on the banking industry to bring some clarity. | Source: Joe Rogan Experience / YouTube

Speaking in front of the US Congress today, US Federal Reserve Chair Jerome Powell said clarity is needed for US banks dealing with cannabis companies.

Marijuana is illegal under Federal law but legal now in 10 US states creating conflict for financial institutions. A number of pot stocks are pushing higher today on this and other news.

A Difficult Place for Financial Institutions

Powell was asked by Democratic Senator Bob Menendez if banks needed clarity in order to assess how to deal with cannabis businesses in US states where the substance is now legal. Powell said that clarity would be “great” adding:

Financial institutions and their regulators and supervisors are in a very difficult position here with marijuana being illegal under federal law and legal under a growing number of state laws.

The current regulatory conflict, the Fed chair says, puts banks and their supervisory bodies in a “difficult place.” Insurance providers also need such clarity in order to address demand from the growing new sector.

A Congressional hearing took place earlier this month focused on banking problems for state-legal cannabis companies. Nearly 100 cannabis-related businesses filed written testimony requesting banking reform.

As the legalization of cannabis takes hold across the US, following Canada’s 2018 lead, it looks likely that clarity for US banks will come in 2019.

Pot Stocks Rising On Deals and Analysts Coverage

Powell’s comments may well help the banking issue though marijuana is not under the Fed’s remit. They certainly have done no harm as a number of pot stocks post increases on Tuesday.

Aurora Cannabis Inc is seeing 4% gains so far recouping some of its loss from earlier in February. It also announced its 51% ownership of Portugal-based Gaia Pharm today. Gaia received approval a few days ago to build an EU-compliant cannabis growing facility. Portugal approved medical cannabis in January of this year.

Shares of Aphria Inc are up over 5% in today’s trading session. The company has revealed a deal with Manna Molecular Science to develop cannabidiol (CBD) patches for both medical and recreational use. Aphria has five-year exclusivity on the new product. Its stock has now doubled in value since a dip in December. Aphria stock’s three largest institutional owners are Morgan Stanley, Vanguard Group Inc and Manufacturers Life Insurance Company. Morgan Stanley owns 2.59% of Aphria’s entire stock at a value of over $62 million and Manufacturers Life owns 1.78%.

Pot Stocks Tick Upwards: Aurora Cannabis (Blue) Aphria Inc (Red) Cronos Group (Orange) OrganiGram Holdings (Yellow) Canopy Growth (Green) Tilray Inc (Bright Green) Five Day Stock Performance Source: Trading View

Analysts Jefferies added coverage of five new cannabis stocks, also boosting the sector. Cronos Group shares are up over 7% and OrganiGram Holdings stock is up over 7.6%. Canopy Growth shares have also risen over 5% and Tiray Inc over 3% at the time of writing. Jefferies rates Aurora Cannabis a “buy” and Canopy Growth a “hold.”

Just days ago wealth manager Carol Pepper named pot stocks the “next huge growth area” predicting that with a physical product behind the market, the sector is unlikely to crash back like Bitcoin has recently.

Featured Image from Joe Rogan Experience/YouTube

You May Also Like

Deutsche Bank Reveals the Real Reason Stock Market Is at All-Time Highs (& Why It Can’t Continue)

The US stock market is at all-time highs, but what’s driving this ten-year bull market? It’s stock buybacks, according to Deutsche Bank.

Dow Futures Rocket but Warren Buffett’s $128 Billion Skips Overpriced Market

Dow Jones Industrial Average (DJIA) futures point to new stock market highs, so why is Warren Buffett reluctant to invest?

US Steel (NYSE:X) Needs More Than Trump Tariffs to End 2019 in the Green

US Steel (NYSE:X) rose swiftly after President Donald Trump announced the reimposition of tariffs on imports from Brazil and Argentina.

Growth Recession Chokes India as GDP Tumbles, and No One Seems to Care

India’s GDP growth fell to a six-year low in Q2, but the country’s government is in denial while the economy reels under a recession.

Dow Pops While Trump Trade War Hits Unsettling Milestone

The Dow kicked off December with a recovery, but stock market bulls must wrestle with an unsettling trade war milestone.

5 Reasons Why the Dow Suffered a 200-Point Nosedive Today

The Dow Jones recoiled on Monday, relinquishing its gains and diving more than 200 points into decline. Here are five reasons why.